Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial

J Clin Anesth. 2016 Dec:35:107-113. doi: 10.1016/j.jclinane.2016.07.030. Epub 2016 Aug 10.

Abstract

Objective: To determine if reversing a deep or moderate block with sugammadex, compared with a shallow block reversed with neostigmine, reduces the time to operating room discharge after surgery and the time spent in the postanesthesia care unit.

Design: A randomized controlled trial.

Setting: Monocentric study performed from February 2011 until May 2012.

Patients: One hundred consenting women with American Society of Anesthesiologists grade I or II were randomized into 2 groups.

Intervention: Laparoscopic hysterectomy was performed under desflurane general anesthesia. For the neostigmine (N) group, 0.45 mg · kg-1 rocuronium was followed by spontaneous recovery. A 5-mg rescue bolus was administered only if surgical evaluation was unacceptable. At the end of surgery, 50 μg · kg-1 neostigmine with glycopyrrolate was administered. For the sugammadex (S) group, a higher intubating rocuronium dose (0.6 mg · kg-1) was followed by 5-mg boluses each time the train-of-four count exceeded 2. Sugammadex (2-4 mg · kg-1) was administered to reverse the block. All patients were extubated after obtaining a train-of-four ratio of 0.9.

Measurements: The duration between the end of surgery and operating room discharge and the time spent in the postanesthesia care unit.

Main results: The time till operating room discharge was shorter and more predictable in group S (9.15±4.28 minutes vs 13.87±11.43 minutes in group N; P=.005). The maximal duration in group S was 22 minutes, compared with 72 minutes in group N. The time spent in the postanesthesia care unit was not significantly different (group S: 47.75±31.77 minutes and group N: 53.43±40.57 minutes; P=.543).

Conclusion: Maintaining a deep neuromuscular block during laparoscopic hysterectomy reversed at the end of the procedure with sugammadex enabled a faster and more predictable time till operating room discharge than did the classical combination of a shallower block reversed with neostigmine.

Keywords: Neostigmine; Neuromuscular blockade; Recovery room; Rocuronium; Sugammadex.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Androstanols / administration & dosage
  • Androstanols / adverse effects
  • Androstanols / antagonists & inhibitors*
  • Anesthesia Recovery Period
  • Anesthesia, General
  • Anesthetics, Inhalation / administration & dosage
  • Desflurane
  • Female
  • Glycopyrrolate / administration & dosage
  • Humans
  • Hysterectomy
  • Isoflurane / administration & dosage
  • Isoflurane / analogs & derivatives
  • Laparoscopy
  • Middle Aged
  • Muscarinic Antagonists / administration & dosage
  • Neostigmine / administration & dosage*
  • Neuromuscular Blockade / economics
  • Neuromuscular Blockade / methods*
  • Neuromuscular Nondepolarizing Agents / administration & dosage
  • Neuromuscular Nondepolarizing Agents / adverse effects
  • Neuromuscular Nondepolarizing Agents / antagonists & inhibitors*
  • Operating Rooms / economics
  • Operative Time
  • Patient Discharge / economics
  • Rocuronium
  • Sugammadex
  • Time Factors
  • gamma-Cyclodextrins / administration & dosage*

Substances

  • Androstanols
  • Anesthetics, Inhalation
  • Muscarinic Antagonists
  • Neuromuscular Nondepolarizing Agents
  • gamma-Cyclodextrins
  • Sugammadex
  • Neostigmine
  • Desflurane
  • Isoflurane
  • Glycopyrrolate
  • Rocuronium